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The urge to have one’s own biological child supersedes any desire in life. Several options have been used to obtain
gametes including pluripotent stem cells (embryonic ES and induced pluripotent iPS stem cells); gonadal stem cells
(spermatogonial SSCs, ovarian OSCs stem cells), bone marrow, mesenchymal cells and fetal skin. However, the field poses
a huge challenge including inefficient existing protocols for differentiation, epigenetic and genetic changes associated
with extensive in vitro manipulation and also ethical/regulatory constraints. A tremendous leap in the field occurred using
mouse ES and iPS cells wherein they were first differentiated into epiblast-like cells and then primordial germ cell-like cells.
These on further development produced sperm, oocytes and live offspring (had associated genetic problems). Evidently
differentiating pluripotent stem cells into primordial germ cells (PGCs) remains a major bottleneck. Against this backdrop,
we propose that a novel population of pluripotent stem cells termed very small embryonic-like stem cells (VSELs) may
serve as an alternative, potential source of autologus gametes, keeping in mind that they are indeed PGCs surviving in
adult mammalian ovaries and testes. Both VSELs and PGCs are pluripotent, relatively quiescent because of epigenetic
modifications of parentally imprinted genes loci like Igf2-H19 and KCNQ1p57, share several markers like Stella, Fragilis,
Mvh, Dppa2, Dppa4, Sall4, Blimp1 and functional receptors. VSELs are localized in the basement membrane of
seminiferous tubules in testis and in the ovary surface epithelium. Ovarian stem cells from mouse, rabbit, sheep,
marmoset and humans (menopausal women and those with premature ovarian failure) spontaneously differentiate
into oocyte-like structures in vitro with no additional requirement of growth factors. Thus a more pragmatic option to
obtain autologus gametes may be the pluripotent VSELs and if we could manipulate them in vivo – existing ethical
and epigenetic/genetic concerns associated with in vitro culture may also be minimized. The field of oncofertility may
undergo a sea-change and existing strategies of cryopreservation of gametes and gonadal tissue for fertility
preservation in cancer patients will necessitate a revision. However, first the scientific community needs to arrive
at a consensus about VSELs in the gonads and then work towards exploiting their potential.
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Gametes derived from pluripotent stem cells may pro-
vide potential reproductive options to individuals who
are rendered infertile due to injuries, exposure to toxi-
cants or immune-suppressive treatments, in cases with
gonadal insufficiency due to premature ovarian failure or
azoospermia, reproductive aging and idiopathic cases of
poor gametes quality and IVF failure. These artificial* Correspondence: deepa.bhartiya@yahoo.in
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unless otherwise stated.gametes derived from stem cells may also serve as an in-
valuable model system to study both genetic and epigen-
etic programming of germ cells development in vivo and
also help obtain better insights into causes for idiopathic
cases of infertility. Premature ovarian failure (POF) is a
heterogeneous disorder that occurs at the frequency of
less than 1% in women less than 40 years of age. Besides
genetic basis and autoimmune etiologies, POF is caused
by surgical removal of ovaries for conditions such as se-
vere endometriosis, cancer and also as a side effect of
oncotherapy for various non-gynecological malignancies.
Similarly, besides a genetic basis, azoospermia in menl Ltd. This is an Open Access article distributed under the terms of the Creative
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option to preserve fertility prior to oncotherapy by way
of cryopreservation of gametes or embryos is not yet
widely available in several countries and also not useful
to young pre-pubertal cancer patients due to non-
availability of gametes. Women willingly go through 6–
7 failed IVF cycles with a hope to become pregnant.
However, assisted reproductive technologies of IVF and
ICSI fail to benefit 30% of couples diagnosed with un-
explained infertility and in cases where patients are en-
tirely devoid of viable gametes. Donor gametes or
adoption are available options however, the urge to
have one’s own biological child supersedes any other
desire in life. Recent advances in the field of reproduct-
ive medicine are focused on exploiting pluripotent stem
cells to differentiate into gametes with a hope to deal
with infertility.
First human pluripotent embryonic stem (hES) cell lines
were reported more than 15 years ago [1] but their induc-
tion into gametes remains highly inefficient till date. A re-
cent 2014 Views and Reviews section in Fertility and
Sterility was dedicated to stem cells, their differentiation
into germ cells and the related efforts towards translation.
To summarize it is still a long way before realizing clinical
potential of stem cells to make gametes for reproductive
medicine [2]. We encourage the readers to refer these
publications for latest update in the field [3-7]. Our review
provides an altogether a different perspective to overcome
existing hurdles to obtain gametes from stem cells. We
put forth our case in favor of VSELs as an alternative
source of pluripotent stem cells to obtain gametes.
Pluripotent stem cells differentiation into gametes –
recent advances
A careful review of published literature shows that a group
from Japan, including Prof. Hayashi and Prof. Saitou has
achieved major progress in the field of generating gametes
from mouse pluripotent stem cells (mES/iPS cells). In
2011 they published in Cell that it is possible to obtain live
pups from sperm derived from pluripotent stem cells (ES
or iPS cells) [8]. In 2012 they published in Science that fol-
lowing a similar strategy, offspring are obtained from oo-
cytes derived from ES or iPS cells [9]. In 2013, they have
published their detailed protocols in Nature Protocols de-
scribing the method to generate eggs starting with mouse
ES cells and iPS cells [10]. Basic reasoning that led to this
remarkable success was that it is important to recapitulate
in vitro what happens in vivo during early embryo devel-
opment. Two main strategies that have been used in the
past to induce germ cells from pluripotent stem cells
(PSCs) include (i) spontaneous differentiation of PSCs to
make embryoid bodies (EBs), isolate cells expressing germ
cell markers for further manipulation and (ii) to use
mouse epiblast stem cell lines to obtain germ cells. Boththese approaches, although provide proof of concept that
it may be possible to differentiate PSCs into germ cells, re-
main highly inefficient. Primordial germ cells (PGCs) are
available in very few numbers and are relatively quiescent
and thus the embryonic germ cell lines derived from them
[11] have shown limited long-term proliferation potential
[12]. Thus Hayashi’s group carried out experiments to first
differentiate PSCs into epiblast-like cells and then induced
them into PGC-like cells (PGCLCs). They demonstrate
that once PGCLCs are obtained, it is possible to transplant
them into testis/ovary to enable their further differenti-
ation into sperm or oocytes respectively resulting in
offspring. It is important to note that in both the publi-
cations, Hyashi et al. [8,9] have reported existence of
genetic anomalies in the offspring. When PSCs were in-
duced to undergo spermatogenesis, some of the off-
spring underwent premature deaths because of tumors
around the neck region. Similarly reduced number of
pups were obtained from PSCs (3.9%) compared to those
obtained by transplanting E12.5 PGCs (12.7%) or 3 weeks
oocytes derived pups (17.3%). Almost half of the PSCs-
derived oocytes failed to extrude second polar body result-
ing in 3PN zygotes. This is not surprising since extended
cultures of ES/iPS cells are bound to result in the acquisi-
tion of genetic and epigenetic alterations during in vitro
culture and parallel studies in humans remain a distant
dream [2,13]. Besides them, few other groups have also re-
ported that PGCs have the ability to undergo gametogen-
esis when transplanted in adult tissues. Chuma et al. [14]
transplanted PGCs in testis and obtained mature sperm
whereas Matoba et al. [15] reported that PGCs isolated
from E12.5 male fetus under the kidney capsule yield sper-
matids. Both these groups reported birth of healthy off-
spring. Similarly Matoba et al. [15] and Hashimoto et al.
[16] reported that PGCs isolated from female fetus when
transplanted under the ovarian bursa or kidney capsule re-
sult in functional eggs. It is intriguing to note that off-
spring born when starting with PGCs are normal
compared to when starting with ES/iPS cells. Hayashi
et al. [17] reviewed recent advances towards obtaining hu-
man gametes to treat infertility. They highlighted the
existing hurdles in the existing differentiation protocols
and discuss alternative use of germline stem cells (SSCs
or OSCs) as a source to produce synthetic gametes
(Figure 1). It may also be possible to obtain germ cells
by transdifferentiation of somatic cells e.g. bone mar-
row and mesenchymal cells. Efforts are also ongoing to
mature the primordial follicles in ovarian cortical tissue
which are cryopreserved prior to cancer therapy.
Differentiation of germline stem cells (SSCs and OSCs)
into gametes
Work on spermatogonial stem cells (SSCs) has progressed
and recent reports suggest that it may be possible to
Figure 1 Left yellow panel depicts event that occur naturally. Right purple panel represents human efforts to make synthetic gametes.
Fertilization of gametes results in a blastocyst with inner cell mass (ICM) which comprises of pluripotent cells (grown in vitro as ES cells) and
further develops into a epiblast-stage embryo where specification into somatic cells and primordial germ cells (PGCs) occurs. PGCs are pluripotent,
express nuclear OCT-4, differentiate into gonocytes in testes and primordial follicles in ovaries (please refer to the main text for greater details)
and persist in adult gonads as pluripotent, nuclear OCT-4 positive VSELs. Thus in addition to SSCs and OSCs in testes and ovaries [42], VSELs also
exist [48] as reviewed recently. VSELs self-renew and give rise to progenitors (SSCs in testis and OSCs in ovary) which undergo clonal expansion,
meiosis and further differentiation into gametes. Solid blue arrows represent asymmetric cell division of VSELs [48]. Differentiation of ES and iPS
cells into synthetic gametes is a distant dream as they do not efficiently differentiate into PGCs. VSELs and OSCs spontaneously differentiate into
oocyte-like structures in vitro [43,63,74-76,78,79] as they are indeed PGCs that survive into adulthood. Limited success has been achieved using
bone marrow [27-29], fetal skin [30] and mesenchymal cells [31-33] possibly because they have VSELs present as a sub-group. Please note that
brown color in the yellow panel represents pluripotent nuclear OCT-4 positive cells.
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in vitro in mice [18] and also in men [19]. However, on
transplantation –these cells are able to colonize but dif-
ferentiation remains inefficient. Recent success was re-
ported by Hermann et al. [20] who obtained functional
sperm after autologus SSCs transplantation in non-
human primates which after IVF also resulted in the
formation of blastocysts. However lot more work needs
to be done before it can reach the clinic and for more
reading in this area readers may refer to recent reviews
[21,22]. Tilly’s group has made significant contributions
to the field of ovarian stem cells (OSCs) since their first
landmark paper challenging the basic dogma that femalesare born with fixed number of eggs [23]. OSCs are local-
ized in the ovary surface epithelium and can be isolated
from the ovarian cortex, expanded in culture and later
transplantation in adult mice - they differentiate into func-
tional eggs and result in offspring [24]. Recently the same
group isolated human OSCs, injected in human cortical
tissue and on transplantation in immuno-deficient mice
demonstrated follicle formation [25]. Several groups are
working extensively to mature primordial follicles from
cortical tissue slices which include techniques like in vitro
growth and in vitro maturation however challenges re-
main to be overcome and to develop a perfect culture to
obtain a healthy oocyte from primordial follicle [26].
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Bone marrow has been reported to be a potential source
for female [27] as well as male [28] germ cells. Kashani
et al. [29] showed that retinoic acid can induce differen-
tiation of mouse bone marrow stem cells into male germ
cells. This concept of transdifferentiation of somatic cells
into germ cells is intriguing and Dyce et al. [30] were re-
cently able to differentiate both male and female porcine
skin fibroblasts to yield oocyte-like cells but more work
needs to be undertaken to obtain functional oocytes.
Similarly mesenchymal cells have also been proposed to
transdifferentiate into germ cells [31-33]. However, the
field remains controversial since we and others have re-
ported that indeed bone marrow [34,35] as well as
MSCs [36] have a sub-group of pluripotent very small
embryonic-like stem cells (VSELs) which could possibly
be responsible for the observations made by various
groups (Figure 1). Liu et al. [37] reported that MSCs do
not differentiate into sperm but rather heal the damaged
testes.
Primordial germ cells and gametogenesis in mammals
A critical review of literature involving differentiation
of PSCs into gametes in vitro shows that the crucial
step is to differentiate PSCs into PGCs. This has
remained a major bottleneck. The PGCs appear to be
pre-programmed and easily differentiate into gametes
(Figure 1). This section reviews available understanding
as to how the PGCs develop and lead to formation of
gametes. Early embryonic development and differenti-
ation of germ cells from the PGCs has been nicely
reviewed recently [38,39]. PGCs arise in proximal epiblast
on E7.5 in mice, migrate along the dorsal mesentery-
through the aorta-gonad-mesonephros (AGM) region to
settle in the gonadal ridge and proliferate in large numbers
(from 150 cells on E8.5 to approximately 25,000 cells at
E13.5). There exists an intriguing overlap between PGCs
migration along the dorsal mesentery and primitive
hematopoiesis which is initiated at about the same time in
the AGM [40]. Being pluripotent, PGCs are capable of
giving rise to both the germ cells as well as the cells of
hematopoietic system. By E13.5, PGCs within the genital
ridge cease dividing; those in the female enter meiosis and
those in the male undergo mitotic arrest. By E15.5, oogo-
nia are formed in females whereas in males they are
termed gonocytes. At birth, the gonocytes undergo rapid
proliferation to form spermatogonia that further prolifer-
ate and differentiate into spermatocytes and undergo mei-
osis to form sperm. Small proportion of spermatogonial
stem cells (with ability to self-renew and further differenti-
ate into sperm) survive in the testis throughout life. Simul-
taneously, in females the oogonia further differentiate and
assemble as primordial follicles during perinatal period
and a female has fixed number of follicles which latermature after puberty under the influence of gonadotro-
pins. PGCs seem to disappear from both ovary and testis
after fetal development or during postnatal period. SSCs
are the stem cells in the testes whereas existence of ovar-
ian stem cells is still debated. Mounting evidence with
seminal contributions of Prof Tilly [41,42], Prof Bukovsky
[43] and others is suggestive of existence of stem cells in
adult ovary. Data from our lab suggests that PGCs pos-
sibly survive in adult ovary and testis as VSELs [44-48]
similar to that reported in bone marrow and other adult
organs [35]. The presence of VSELs in the gonads as well
as in the bone marrow may explain the plasticity observed
by various groups and ability of bone marrow cells to
differentiate into germ cells [27-29].
Primordial germ cells survive in gonads and other body
organs as VSELs in adult mammals including humans
Ratajczak’s group have suggested that the PGCs/their
precursors during their migration not only migrate to
the gonadal ridges but indeed settle down in various
adult organs and serve as a back-up pool of pluripotent
stem cells to give rise to tissue specific stem cells to
maintain homeostasis [35,49,50]. Owing to their small
size (3–6 μm) and because they express long telomeres
and pluripotent markers [Oct-4, Nanog, Rex-1, SSEA-1
(mice) and SSEA-4 (humans)], these cells are termed very
small embryonic-like stem cells (VSELs). VSELs can be
sorted as Sca + LIN-CD45- in mice and as CD133 + LIN-
CD45- in humans. Similar to ES cells, VSELs also are posi-
tive for alkaline phosphatase, have a distinct spherical
shape with a large nucleus surrounded by a thin rim of
cytoplasm and high nucleo-cytoplasmic ratio. Shin et al.
[51] reported that mouse bone marrow VSELs have tran-
scriptionally active chromatin structures for both Oct-4
and Nanog promoters. Their pluripotent state is shown by
their ability to self-renew and differentiate in vitro into all
three germ layers in both mice [52] and humans [53].
VSELs get mobilized in circulation in response to injury
[52,54-58] to regenerate damaged tissues and also in re-
sponse to G-CSF treatment [59].
After gastrulation, majority of epiblast stem cells lose
expression of pluripotency transcription factors and fur-
ther develop into somatic organs whereas the pluripo-
tency markers are selectively expressed in the PGCs
(Figure 1). Various evidence to suggest that VSELs which
exist in adult body organs could possibly be the PGCs or
their precursors is summarized in Table 1 and has been
elaborately studied by Ratajczak’s group [35,40,60,61].
This is supported by (i) both PGCs and VSELs are pluri-
potent and relatively quiescent in nature (ii) quiescent na-
ture of both PGCs and VSELs is due to similar epigenetic
modification of paternally imprinted genes like Igf2-H19
and KCNK1p57 (iii) both express Stella, Fragilis, Blimp1,
Mvh (iv) late migrating PGCs specific markers including
Table 1 Current understanding and comparison of PGCs with VSELs isolated from mouse bone marrow and adult 720
mouse and human ovary and testis
1 PGCs versus VSELs isolated from mouse bone marrow [40,50,59]
VSELs have been studied in details and compared to PGCs based on available literature but a direct comparison of the two has yet not been made
• PGCs are pluripotent cells derived from epiblast stage embryo whereas VSELs are pluripotent stem cells detected in mouse bone marrow
(and other adult body organs). Both have a distinct spherical shape, large nucleus, a thin rim of cytoplasm and long telomeres · VSELs are more
differentiated than inner cell mass-derived ESC and share a lot of markers with EpiSC (Gbx2, Fgf5 and Nodal).
• VSELs exhibit similarity in gene expression and epigenetic signatures to epiblast-derived migratory PGCs (but not post-migratory PGCs). However
some differences do exist in the gene expression which could be explained by the effect of the niche where they reside (genital ridge for PGCs
and bone marrow for VSELs).
• VSELs and the PGCs exhibit similar mechanism of imprinting erasure. Global erasure of parental imprints occurs in PGCs whereas in VSELs erasure
mainly on paternally imprinted DMRs (H19-Igf2, RasGRF1) has been reported. DMRs for selected maternally methylated genes (Kcnq1, Igf2R) in
PGCs – are hypermethylated in VSELs. In contrast to PGCs, VSELs exhibit an erasure of imprint especially for paternally imprinted DMRs
• Stella promoter in VSELs like in PGCs is partially demethylated and shows transcriptionally active histone modifications (H3Ac and H3K4me3)
• Bone marrow VSELs express at both mRNA and protein levels, genes specific to epiblast (e.g. Stella, Fragilis and Blimp 1) and also those specific
to migratory PGCs specification e.g. Dppa2, Dppa4 and Mvh. Both express pluripotent markers including nuclear Oct-4, Nanog, Rex-1, SSEA-1. Both
express CXCR4 which is responsible for their migration/mobilization.
• VSELs express several pituitary and gonadal hormone receptors and Sall4 (an early marker shared by germ and hematopoietic cells).
• VSELs similarly like PGCs could be specified to hematopoietic lineage.
2 Adult mouse and human testis & ovary VSELs compared to bone marrow VSELs [45,46,63,74]
• Mouse bone marrow VSELs are LIN-/CD45-/SCA-1 +. Similarly VSELs isolated from the mouse ovary and testis are LIN-/CD45-/SCA-1 + .
• Both are very small in size, spherical in shape and have high nucleo- cytoplasmic ratio
• Both express pluripotent markers at mRNA and protein level including nuclear OCT-4, Nanog, Rex-1, SSEA-1 (SSEA-4 in humans)
• Gonadotropin receptors (FSHR) have been reported on both gonadal and bone marrow VSELs
• Human ovarian and testicular VSELs were FACS sorted using SSEA-4 as a marker. Both PGCs and human ovarian and testicular VSELs stain positive
for alkaline phosphatase. VSELs express several genes related to pluripotency and self-renewal (POU5F1 (OCT4), SALL4, CDH1, LIN28B, NANOG,
SOX2, SOX11, DPPA3 (STELLA), LEFTY1, ZIC3, ZIC5, PRDM14, GAL, PPP1R9A, RNF2, LASS1 (CERS1), SMO, MMP25, GULP1, MLLT4, BMP7, MYBL2,
DNMT3B, ZFP42, HESRG, ZSCAN10, TRO, GLI2, FBN3 and DDX11) and PGC related genes (VASA, PRDM1, DPPA3)
3 VSELs compared to embryonic stem (ES) cells [47,59,70,74]
• In contrast to ES cells isolated from inner cell mass and iPS cells – VSELs do not form teratomas in SCID mice nor complement blastocyst
development. This basic difference between these two populations of pluripotent stem cells is due to novel epigenetic mechanism of imprint
erasure on paternally imprinted DMRs (H19-Igf2, RasGRF1) exhibited by VSELs
• VSELs express pluripotent transcripts like ES cells but several folds low expression is reported
• 341 genes were down regulated and 435 genes were up regulated when hES cells were compared to VSELs isolated from human ovary.
Interestingly genes like H19 (maternally imprinted gene), VASA (germ cell marker) and PLD6 (required for gametogenesis and meiosis) were up
regulated in VSELs compared to hES cells [70].
• ES cells undergo symmetric cell divisions, are immortal in vitro and give rise to cells of all three lineages. VSELs remain quiescent and do not
readily divide in culture. They self-renew under special conditions and are capable of giving rise to cells of all three lineages e.g. VSELs in ovary
surface epithelium respond to FSH, undergo self-renewal and clonal expansion (evidenced by germ cell nest formation) followed by differentiation
into oocytes both in vitro [70] and in vivo [47].
• Distinct expression profile of VSELs shows that they are more related to PGCs than ES cells and thus have the potential to
spontaneously differentiate into gametes.
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VSELs also express several miRNAs that attenuate Igf-1/
Igf-2 signaling in these cells (mir681, mir470, mir669b) as
well as up regulate expression of p57 (mir25.1, mir19b,
mir92). VSELs have recently been also shown to express
functional receptors for genes involved in PGCs specifi-
cation into gametes. Based on the developmental origin
of VSELs, their proliferation, like PGCs, is controlled by
the DNA methylation state of some of the develop-
mentally crucial imprinted genes (e.g. H19, Igf2, and
Rasgrf1). During the ageing process, proliferation-
repressive epigenetic marks progressively disappear,resulting in the increased sensitivity to Ins/Igf signaling
and thus depletion of VSELs [62]. A direct developmen-
tal link between PGCs and hematopoiesis was recently
discussed by Kucia et al. [40]. A lot of overlap exists
among chromosomal aberrations between germline tu-
mors and leukemias or lymphomas suggesting their
clonal origin from common precursor VSELs. Thus it is
likely that a common population of VSELs exists in
adults that undergoes hematopoiesis in bone marrow
and gametogenesis in the gonads. It is time to think
beyond the existing paradigm that PGCs migrate only
to the gonadal ridge and give rise to germ cells – rather
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and survive throughout life serving as a backup pool for
tissue committed stem cells.
VSELs (PGCs) have been reported in adult human
[45] and mouse [44,63] testis. They are localized in the
basal seminiferous epithelium of testicular tubules.
Similarly they are localized in the adult mouse, rabbit,
sheep, marmoset and human ovary surface epithelium
[48,64]. To conclude, in addition to the OSCs reported
by Tilly’s group in adult mouse ovary surface epithe-
lium as equivalent to SSCs in the testis [42], we have
accumulated evidence for the presence of an additional
population of pluripotent stem cells termed VSELs in
both adult ovary and testis (Figure 1). VSELs are rela-
tively quiescent and express nuclear OCT-4 along with
other pluripotent transcripts whereas the SSCs/OSCs
divide rapidly with incomplete cytokinesis and express
cytoplasmic OCT-4 [48]. Thus we propose that pluripo-
tent VSELs give rise to the SSCs/OSCs which further
differentiate and undergo meiosis to form haploid gam-
etes (Figure 1). This stem cell biology in the gonads is
strictly under the control of the somatic microenviron-
ment/niche. With increased age the niche function
(source of growth factors and cytokines crucial for stem
cells differentiation) gets compromised and perhaps
this results in menopause as suggested by others also
[65]. Moreover, uncontrolled proliferation of VSELs
possibly results in tumors [66,67]. It is interesting to
note that nuclear OCT-4, a marker for VSELs is also
being reported as a specific and sensitive marker for
testicular tumors [68] and also in ascites fluid of ovar-
ian cancer patients [69].
Thus of the two models proposed by Felici and Barrios
[38], we agree with the second model which suggest the
existence of a small population of VSELs amongst OSCs/
FGSCs in ovary and also a similar sub-population of
VSELs exists amongst SSCs in the testes. VSELs undergo
characteristic asymmetric cell division wherein they self-
renew and also give rise to SSCs/OSCs which undergo
rapid symmetric cell division and further meiosis and dif-
ferentiation to form haploid gametes (Figure 1). We have
further shown that these VSELs are indeed responsible for
neo-oogenesis and primordial follicle assembly in mice
[47], are regulated by FSH [70], form Balbiani bodies,
undergo cytoplasmic streaming and germ cell clusters
do form during the process in adult ovary [46,71] as
against the recent conclusions made by Lei and Sprad-
ling [72]. Parte et al. [46] have reported that adult
peri-menopausal ovarian VSELs express Stella and
Fragilis (specific markers for PGCS) suggesting that
the VSELs are indeed the PGCs that survive into
adulthood.
We have further observed that VSELs in the mouse ovary
and testis survive chemotherapy (personal observations) inagreement with earlier report in mouse bone marrow after
total body irradiation [73]. VSELs exist in otherwise azoo-
spermic testes of survivors of childhood cancer (personal
observations) and may also exist in the ovaries which
undergo pre-mature failure due to oncotherapy – but are
unable to differentiate because the somatic niche gets com-
promised as a result of oncotherapy. It will indeed be of
interest to study whether these persisting VSELs (PGCs) in
chemoablated testes and ovaries can spontaneously differ-
entiate into gametes in vitro. Anand et al. [74] recently re-
ported that testicular VSELs in mice survive busulphan
treatment and readily undergo spermatogenesis when a
healthy niche is provided.
Table 1 summarizes the similarity between bone mar-
row VSELs and PGCs, adult gonadal and bone marrow
VSELs and also between VSELs and embryonic stem
cells. It is clearly evident that VSELs are pluripotent in
nature like ES cells and PGCs but unlike ES cells, ex-
press PGCs specific markers and epigenetic profile.
Genes like H19 (maternally imprinted gene), VASA (germ
cell marker) and PLD6 (required for gametogenesis and
meiosis) are up regulated in VSELs compared to hES cells.
This distinct expression profile of VSELs isolated from
adult human ovary shows that they are more related to
PGCs than ES cells.
Ovarian VSELs express FSHR, respond to gonadotropins
and undergo neo-oogenesis in adult mouse ovary
Using adult mice, our group has recently documented the
effect of ovarian stimulation on the stem cells (VSELs and
OSCs) localized in the OSE [47]. Ovaries were studied after
2 and 7 days of treatment with FSH analog (pregnant mare
serum gonadotropin PMSG, 5 IU). The changes observed
were not related to ovulation since the mice were not ad-
ministered HCG. We showed that stem cells localized in
the OSE respond to PMSG and undergo proliferation,
clonal expansion to form germ cell nests, meiosis and dif-
ferentiate into oocyte-like structures which assemble as
primordial follicles. Thus in addition to FSH action on the
growing follicles, FSH also has a crucial role in regulating
neo-oogenesis in adult ovary from the stem cells localized
in the OSE. Detailed studies in sheep show that ovarian
stem cells express FSHR, respond to FSH via alternatively
spliced FSHR transcript FSHR3 and germ cell nests were
observed after 15 hrs of treatment [70]. Kucia et al. [59]
also reported presence of pituitary and gonadal hormone
receptors on bone marrow VSELs. The VSELs multiply
and show enhanced BrdU uptake in response to stimula-
tion by danazol, FSH, LH, PMSG and sex hormones.
Spontaneous differentiation of ovarian stem cells into
oocyte-like structures and parthenotes in vitro
Bukovsky et al. [43,75] first demonstrated differentiation
of surface epithelium of post-menopausal human ovary
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Oocyte-like structures were obtained in vitro using sam-
ples collected from menopausal women as well as those
who had premature ovarian failure unlike the conven-
tional IVF procedure where maternal age more than
35 years is considered as a high risk due to the genetic
abnormalities. Later Virant-Klun and her group [76-78]
reported that very small, embryonic-like, spherical cells
could be isolated by OSE scraping of postmenopausal
and women with pre-mature ovarian failure. They also
reported spontaneous development of oocyte-like struc-
tures and parthenogenetic blastocyst-like structures with
normal ploidy status. Our group observed that OSE cells
from adult rabbits, monkey, sheep and peri-menopausal
women (who are otherwise devoid of follicles) when put
in culture for three weeks result in spontaneous differenti-
ation of oocyte-like, parthenote-like, embryoid body-like
structures and also embryonic stem cell-like colonies
whereas epithelial cells attach and transform into a bed of
mesenchymal cells possibly by a process of epithelial-
mesenchymal transition [63]. We also noted that the pres-
ence of germ cell nests, Balbiani body-like structures and
cytoplasmic streaming extensively described during fetal
ovary development, are indeed well recapitulated dur-
ing in vitro oogenesis in adult human OSE cultures
along with characteristic expression of stem/germ cell/
oocyte markers [46]. Time lapse imaging of developing
oocyte –like cells with distinctly moving cytoplasmic ex-
tensions have also been reported by Bukovsky’s group
[43,79].
The striking fact is the spontaneous nature of this kind
of differentiation of VSELs into oocyte-like structures. No
additional growth factors are added to the medium to
induce differentiation of oocyte-like structures. It ap-
pears that the VSELs in the OSE scrapings are pre-
programmed to differentiate into oocytes. This is indeed
facilitated by the epithelial cells which form a bed of fibro-
blasts and were present in close association with the dif-
ferentiating stem cells. Similarly the isolated OSCs also
undergo spontaneous differentiation into oocytes in cul-
ture [25,43,80]. Parte et al. [81] have shown that ovarian
cortical tissue slices besides being a source of primordial
follicles are also an excellent source of stem cells that
spontaneously differentiate into oocyte-like structures
after 3 weeks culture. Evidently the reason for this spon-
taneous differentiation of VSELs into oocyte-like struc-
tures is that the VSELs closely resemble PGCs (Table 1
and Figure 1).
Conclusions
It may be possible to obtain human gametes provided ef-
ficient and directed differentiation of ES or iPS cells into
PGCs is achieved. But this may not be mandatory since
emerging literature suggests that PGCs persist as a sub-population of VSELs along with SSCs in testis and OSCs
in ovary. Similar to the PGCs, VSELs are quiescent in
nature, do not expand in culture like ES or iPS cells and
throughout life serve as a backup pool and give rise to
SSCs/OSCs which undergo clonal expansion, meiosis
and further differentiation to produce haploid gametes.
Ovarian VSELs respond to FSH via FSHR3 and spontan-
eously differentiate into oocyte-like structures in vitro
during OSE culture. Similar in vitro culture studies are
ongoing in our lab using testicular VSELs. More studies
are required to further substantiate the potential of
VSELs and their ability to differentiate into gametes. We
propose that rather than the existing concept of in vitro
differentiation of stem cells into oocytes and sperm for
assisted reproduction, it would be ideal to manipulate
VSELs that survive oncotherapy in vivo to achieve res-
toration of gonadal function (since they exist in meno-
pausal/ POF ovary and also in azoospermic human
testis).
In contrast to genetically affected offspring born
from ES/iPS derived gametes, healthy offspring born
starting with OSCs and the oocytes formed after
in vitro spontaneous differentiation of ovarian stem
cells show normal ploidy status. This is evidently be-
cause of the similar epigenetic status of PGCs and
VSELs which is possibly difficult to be replicated in vitro
while differentiating ES/iPS cells into PGCs (although
some success has been achieved as described above). Sci-
entific community needs to slow down, re-think and
make efforts to exploit clinical potential of pluripotent
stem cells (VSELs) and progenitors (SSCs and OSCs)
which exist in the adult gonads as an alternate option to
ES/iPS cells!
Key messages
 Current status of making gametes from pluripotent
stem cells (ES and iPS) to help infertile couples is
highly inefficient and still remains a distant dream
 Major obstacle in the field is apparently to establish
protocols to obtain primordial germ cells (PGCs)
from the pluripotent stem cells (ES and iPS) in vitro.
PGCs are pre-programmed and hence easily and
spontaneously differentiate into gametes
 Published literature is reviewed suggesting that this
challenge of making gametes can be easily overcome
since PGCs indeed survive in adult human ovaries and
testes as very small embryonic-like stem cells (VSELs)
 VSELs are pluripotent stem cells (surviving PGCs)
which exist as a sub-population localized in the
adult ovary surface epithelium and in the basement
membrane of seminiferous tubules in the testes.
They are present in normal adult and aged testes
and ovaries (including POF and menopausal ovaries).
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their quiescent nature.
 Three weeks culture (simple culture medium with
no added growth factors) of ovary surface epithelial
cells enriched with VSELs and ovary stem cells
(OSCs) spontaneously differentiate into oocyte-like
structures - because the gonadal VSELs (PGCs) and
OSCs (arise from the VSELs) are pre-programmed
to develop into gametes
 We propose that rather than manipulating gonadal
VSELs (PGCs) in vitro, a better approach will be to
manipulate them in vivo to give rise to functional
gametes. This approach will give rise to autologus
gametes, with no associated ethical/regulatory
constraints and epigenetic/genetic issues may not
exist by avoiding in vitro culture.
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